Try our Advanced Search for more refined results

Expert Analysis

Fed. Circ. Clarifies Doctrine Of Equivalents In ANDA Litigation

Law360, New York (July 19, 2016, 11:44 AM EDT) -- In its recent holding in Intendis v. Glenmark, the Federal Circuit affirmed the District of Delaware's decision that generic manufacturer Glenmark infringed a patent covering Finacea gel. Notably, the district court invoked the doctrine of equivalents in arriving at its conclusion and relied upon Glenmark's own assertions that its generic version of the product is equivalent to the name-brand product. In doing so, the court provided much-needed clarity for pharmaceutical patentees and strengthened the protection drug innovators can expect from patents covering their product formulations....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!